343 results on '"Imrich, Richard"'
Search Results
2. Plasma irisin and the brain-derived neurotrophic factor levels in sedentary subjects: effect of 8-weeks lifestyle intervention
3. Electronic structure and molecular properties of nitisinone and mesotrione in water
4. Ab initio study of molecular properties of l-tyrosine
5. Nutritional interventions for patients with alkaptonuria: A minireview
6. Molecular Properties of Branched Aliphatic α‑Amino Acids in Water.
7. Cardiac autonomic function in patients with early multiple sclerosis
8. Molecular Properties of Monoaminergic Catecholamines in Water.
9. Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial
10. Joint Replacement Risk is Markedly Increased in Alkaptonuria (Aku) in Those with Prior Arthroplasty
11. Neuroendocrine Changes in PMR and GCA
12. Immunocompetent Cells and Their Role in Polymyalgia Rheumatica and Giant Cell Arteritis
13. Polymyalgia Rheumatica and Giant Cell Arteritis: An Overview with a Focus on Important Factors Contributing to the Severity of the Disease
14. Effect of 8-weeks intensive lifestyle intervention on LDL and HDL subfractions
15. Alkaptonuria and Ochronosis
16. Pathogenesis, Clinical Syndromology and Treatment of Rheumatoid Arthritis
17. LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity
18. Effect of Solvation on Glycine Molecules: A Theoretical Study
19. Endothelial Function in Patients with Multiple Sclerosis: The Role of GLP-1 Agonists, Lipoprotein Subfractions, and Redox Balance
20. Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
21. Polymyalgia Rheumatica and Giant Cell Arteritis — an overview with a focus on important factors contributing to the severity of the disease
22. Rare Complications of Alkaptonuria: Haemolysis and Amyloidosis
23. Glycoprofiling as a novel tool in serological assays of systemic sclerosis: A comparative study with three bioanalytical methods
24. Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis
25. Autonomic Nervous System Response to Stressors in Newly Diagnosed Patients with Multiple Sclerosis
26. Therapy of Polymyalgia Rheumatica and Giant Cell Arteritis
27. Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies
28. Analysis of the Phenotype Differences in Siblings with Alkaptonuria
29. Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
30. Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
31. Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
32. Hyperinsulinemia in newly diagnosed patients with multiple sclerosis
33. Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index
34. Correction: Zatkova et al. Analysis of the Phenotype Differences in Siblings with Alkaptonuria. Metabolites 2022, 12 , 990.
35. Temporal Adaptations in the Phenylalanine/Tyrosine Pathway and Related Factors During Nitisinone-Induced Tyrosinaemia in Alkaptonuria
36. Cytokines in Polymyalgia Rheumatica and Giant Cell Arteritis
37. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment
38. Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling
39. Effects of a protein‐restricted diet on body weight and serum tyrosine concentrations in patients with alkaptonuria
40. Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögrenʼs Syndrome
41. Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations
42. Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension
43. Adrenomedullary Response to Glucagon in Patients with Primary Sjögren’s Syndrome
44. Autonomic Nervous System Function in Rheumatoid Arthritis
45. Heart rate variability and catecholamines during hypoglycemia and orthostasis
46. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy
47. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
48. Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab
49. Central dopamine deficiency in pure autonomic failure
50. Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.